Engineering Periplasmic Ligand Binding Proteins As Glucose Nanosensors
Overview
Authors
Affiliations
Diabetes affects over 100 million people worldwide. Better methods for monitoring blood glucose levels are needed for improving disease management. Several labs have previously made glucose nanosensors by modifying members of the periplasmic ligand binding protein superfamily. This minireview summarizes recent developments in constructing new versions of these proteins that are responsive within the physiological range of blood glucose levels, employ new reporter groups, and/or are more robust. These experiments are important steps in the development of novel proteins that have the characteristics needed for an implantable glucose nanosensor for diabetes management: specificity for glucose, rapid response, sensitivity within the physiological range of glucose concentrations, reproducibility, and robustness.
Retracing the evolution of a modern periplasmic binding protein.
Michel F, Romero-Romero S, Hocker B Protein Sci. 2023; 32(11):e4793.
PMID: 37788980 PMC: 10601554. DOI: 10.1002/pro.4793.
Nanotheranostics: application of nanosensors in diabetes management.
Pathak K, Saikia R, Sarma H, Pathak M, Das R, Gogoi U J Diabetes Metab Disord. 2023; 22(1):119-133.
PMID: 37255773 PMC: 10225368. DOI: 10.1007/s40200-023-01206-4.
Barani M, Sargazi S, Mohammadzadeh V, Rahdar A, Pandey S, Jha N J Funct Biomater. 2021; 12(4).
PMID: 34698244 PMC: 8544389. DOI: 10.3390/jfb12040054.
The 40-Year Mystery of Insect Odorant-Binding Proteins.
Rihani K, Ferveur J, Briand L Biomolecules. 2021; 11(4).
PMID: 33808208 PMC: 8067015. DOI: 10.3390/biom11040509.
Otten J, Tenhaef N, Jansen R, Dobber J, Jungbluth L, Noack S Microb Cell Fact. 2019; 18(1):143.
PMID: 31434564 PMC: 6704555. DOI: 10.1186/s12934-019-1193-y.